Xiaobao Yang

99 Haike Road, Zhangjiang Hi Tech Park
Zhangjiang, 201210, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Unique Cysteine-Directed Covalent Inhibition of PRMT1 Suppresses Breast Tumorigenesis.

Unique Cysteine-Directed Covalent Inhibition of PRMT1 Suppresses Breast Tumorigenesis.

Journal: Journal of medicinal chemistry

Published: June 17, 2026

CXCL13-expressing CD4+ T cells coordinate the lymphocytes triad to promote the anti-tumor immunity in NSCLC.

CXCL13-expressing CD4+ T cells coordinate the lymphocytes triad to promote the anti-tumor immunity in NSCLC.

Journal: Oncoimmunology

Published: June 10, 2026

The Proximity of PD-1-CD103+ Tissue-Resident CD8+ T Cells to Tumor Cells Is Correlated with Improved Clinical Outcomes in Patients with Cholangiocarcinoma.

The Proximity of PD-1-CD103+ Tissue-Resident CD8+ T Cells to Tumor Cells Is Correlated with Improved Clinical Outcomes in Patients with Cholangiocarcinoma.

Journal: Cancers

Published: December 21, 2025

ZBTB16 controls the onset of Clostridium difficile colitis through the Pyrin inflammasome.

ZBTB16 controls the onset of Clostridium difficile colitis through the Pyrin inflammasome.

Journal: Pharmacological research

Published: November 13, 2025

Deuterium substitution at the intolerable site as a strategy to mitigate the toxicity of camptothecin derivatives.

Deuterium substitution at the intolerable site as a strategy to mitigate the toxicity of camptothecin derivatives.

Journal: European journal of medicinal chemistry

Published: April 12, 2025

PROTAC-loaded nanocapsules degrading BRD4 for radio-chemotherapy sensitization in glioblastoma.

PROTAC-loaded nanocapsules degrading BRD4 for radio-chemotherapy sensitization in glioblastoma.

Journal: Acta pharmaceutica Sinica. B

Published: October 21, 2024

Targeted Degradation of SOS1 Exhibits Potent Anticancer Activity and Overcomes Resistance in KRAS-Mutant Tumors and BCR-ABL-Positive Leukemia.

Targeted Degradation of SOS1 Exhibits Potent Anticancer Activity and Overcomes Resistance in KRAS-Mutant Tumors and BCR-ABL-Positive Leukemia.

Journal: Cancer research

Published: April 02, 2024

Identifying the Spatial Architecture That Restricts the Proximity of CD8+ T Cells to Tumor Cells in Pancreatic Ductal Adenocarcinoma.

Identifying the Spatial Architecture That Restricts the Proximity of CD8+ T Cells to Tumor Cells in Pancreatic Ductal Adenocarcinoma.

Journal: Cancers

Published: March 10, 2024

HDAC6 inhibitor promotes reactive oxygen species-meditated clearance of Staphylococcus aureus in macrophage.

HDAC6 inhibitor promotes reactive oxygen species-meditated clearance of Staphylococcus aureus in macrophage.

Journal: Clinical and experimental pharmacology & physiology

Published: February 23, 2024

Corrigendum to "Discovery of novel BCR-ABL PROTACs based on the cereblon E3 ligase design, synthesis, and biological evaluation" [Eur. J. Med. Chem. 223 (2021) 11-05 113645].

Corrigendum to "Discovery of novel BCR-ABL PROTACs based on the cereblon E3 ligase design, synthesis, and biological evaluation" [Eur. J. Med. Chem. 223 (2021) 11-05 113645].

Journal: European journal of medicinal chemistry

Published: March 29, 2023

Stimuli-activatable PROTACs for precise protein degradation and cancer therapy.

Stimuli-activatable PROTACs for precise protein degradation and cancer therapy.

Journal: Science bulletin

Published: March 01, 2023

Identification of calcium and integrin-binding protein 1 as a reprogrammed glucose metabolism mediator to restrict immune cell infiltration in the stromal compartment of pancreatic ductal adenocarcinoma.

Identification of calcium and integrin-binding protein 1 as a reprogrammed glucose metabolism mediator to restrict immune cell infiltration in the stromal compartment of pancreatic ductal adenocarcinoma.

Journal: Frontiers in immunology

Published: February 04, 2023

Showing 1-12 of 38

Last Updated: 09/26/2026